Your browser doesn't support javascript.
loading
A Comprehensive Evaluation of Sdox, a Promising H2S-Releasing Doxorubicin for the Treatment of Chemoresistant Tumors.
Alov, Petko; Al Sharif, Merilin; Aluani, Denitsa; Chegaev, Konstantin; Dinic, Jelena; Divac Rankov, Aleksandra; Fernandes, Miguel X; Fusi, Fabio; García-Sosa, Alfonso T; Juvonen, Risto; Kondeva-Burdina, Magdalena; Padrón, José M; Pajeva, Ilza; Pencheva, Tania; Puerta, Adrián; Raunio, Hannu; Riganti, Chiara; Tsakovska, Ivanka; Tzankova, Virginia; Yordanov, Yordan; Saponara, Simona.
Afiliación
  • Alov P; Department of QSAR and Molecular Modelling, Institute of Biophysics and Biomedical Engineering, Bulgarian Academy of Sciences, Sofia, Bulgaria.
  • Al Sharif M; Department of QSAR and Molecular Modelling, Institute of Biophysics and Biomedical Engineering, Bulgarian Academy of Sciences, Sofia, Bulgaria.
  • Aluani D; Department of Pharmacology, Pharmacotherapy and Toxicology, Faculty of Pharmacy, Medical University of Sofia, Sofia, Bulgaria.
  • Chegaev K; Department of Drug Science and Technology, University of Torino, Torino, Italy.
  • Dinic J; Department of Neurobiology, Institute for Biological Research Sinisa Stankovic, National Institute of Republic of Serbia, University of Belgrade, Belgrade, Serbia.
  • Divac Rankov A; Institute of Molecular Genetics and Genetic Engineering, University of Belgrade, Belgrade, Serbia.
  • Fernandes MX; BioLab, Instituto Universitario de Bio-Orgánica Antonio González, Universidad de La Laguna, La Laguna, Spain.
  • Fusi F; Department of Biotechnology, Chemistry and Pharmacy, University of Siena, Siena, Italy.
  • García-Sosa AT; Institute of Chemistry, University of Tartu, Tartu, Estonia.
  • Juvonen R; School of Pharmacy, University of Eastern Finland, Kuopio, Finland.
  • Kondeva-Burdina M; Department of Pharmacology, Pharmacotherapy and Toxicology, Faculty of Pharmacy, Medical University of Sofia, Sofia, Bulgaria.
  • Padrón JM; BioLab, Instituto Universitario de Bio-Orgánica Antonio González, Universidad de La Laguna, La Laguna, Spain.
  • Pajeva I; Department of QSAR and Molecular Modelling, Institute of Biophysics and Biomedical Engineering, Bulgarian Academy of Sciences, Sofia, Bulgaria.
  • Pencheva T; Department of QSAR and Molecular Modelling, Institute of Biophysics and Biomedical Engineering, Bulgarian Academy of Sciences, Sofia, Bulgaria.
  • Puerta A; BioLab, Instituto Universitario de Bio-Orgánica Antonio González, Universidad de La Laguna, La Laguna, Spain.
  • Raunio H; School of Pharmacy, University of Eastern Finland, Kuopio, Finland.
  • Riganti C; Department of Oncology, University of Torino, Torino, Italy.
  • Tsakovska I; Department of QSAR and Molecular Modelling, Institute of Biophysics and Biomedical Engineering, Bulgarian Academy of Sciences, Sofia, Bulgaria.
  • Tzankova V; Department of Pharmacology, Pharmacotherapy and Toxicology, Faculty of Pharmacy, Medical University of Sofia, Sofia, Bulgaria.
  • Yordanov Y; Department of Pharmacology, Pharmacotherapy and Toxicology, Faculty of Pharmacy, Medical University of Sofia, Sofia, Bulgaria.
  • Saponara S; Department of Life Sciences, University of Siena, Siena, Italy.
Front Pharmacol ; 13: 831791, 2022.
Article en En | MEDLINE | ID: mdl-35321325
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Front Pharmacol Año: 2022 Tipo del documento: Article País de afiliación: Bulgaria
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Front Pharmacol Año: 2022 Tipo del documento: Article País de afiliación: Bulgaria